Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Cizzle Biotechnology Holdings PLC

CIZ.L ✓ COMPLIANT ☆ Track — members

LSE · Healthcare · Biotechnology & Medical Research ·

UK Micro Cap Analyst: N/A

Last Close

$0.02

▲ +0.00%

Market Cap $9.46M · Vol 2.39M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$9.46M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

10.00

Momentum

Beta

-0.07

vs Market

52W High

$0.05

57.67% below

52W Low

$0.02

39.71% above

Volume

2.39M

Avg 1.98M

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

76.48%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Cizzle Biotechnology Holdings PLC (CIZ.L) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CIZ.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.94%

-23.26%

-48.44%

+22.22%

YTD

+6.45%

+26.92%

-7.50%

-68.57%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-930,978.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-203.80% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	424.96M

Technical Indicators

50-Day SMA	$0.03
200-Day SMA	$0.03
RSI (14)	10.00
Beta	-0.07
52-Week High	$0.05
52-Week Low	$0.02

Volume Today	2.39M
Avg Daily Volume (30D)	1.98M
Relative Volume	1.21x
Volatility (10D)	44.43
Volatility (30D)	54.68
Free Float	76.48%

Analyst Consensus

N/A

Current Price $0.02

Mean Target N/A

52W Low$0.02 52W High$0.05

Current

Target

$0.02 $0.05

Current Analyst target

· 0 analysts

Identifiers

ExchangeLSE

FIGIBBG001SRRCZ3

ISINGB00BNG2VN02

CountryUnited Kingdom

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Cizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.